Inotiv, Inc. (NOTV)
NASDAQ: NOTV · Real-Time Price · USD
0.2780
+0.0170 (6.51%)
At close: Feb 23, 2026, 4:00 PM EST
0.2848
+0.0068 (2.45%)
After-hours: Feb 23, 2026, 7:56 PM EST
Inotiv Revenue
Inotiv had revenue of $120.88M in the quarter ending December 31, 2025, with 0.84% growth. This brings the company's revenue in the last twelve months to $514.03M, up 8.19% year-over-year. In the fiscal year ending September 30, 2025, Inotiv had annual revenue of $513.02M with 4.54% growth.
Revenue (ttm)
$514.03M
Revenue Growth
+8.19%
P/S Ratio
0.02
Revenue / Employee
$251,235
Employees
2,046
Market Cap
9.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 513.02M | 22.29M | 4.54% |
| Sep 30, 2024 | 490.74M | -81.69M | -14.27% |
| Sep 30, 2023 | 572.43M | 24.77M | 4.52% |
| Sep 30, 2022 | 547.66M | 458.05M | 511.19% |
| Sep 30, 2021 | 89.61M | 29.14M | 48.18% |
| Sep 30, 2020 | 60.47M | 16.85M | 38.64% |
| Sep 30, 2019 | 43.62M | 17.27M | 65.55% |
| Sep 30, 2018 | 26.35M | 2.10M | 8.68% |
| Sep 30, 2017 | 24.24M | 3.80M | 18.59% |
| Sep 30, 2016 | 20.44M | -2.26M | -9.94% |
| Sep 30, 2015 | 22.70M | -1.89M | -7.67% |
| Sep 30, 2014 | 24.58M | 2.52M | 11.40% |
| Sep 30, 2013 | 22.07M | -6.14M | -21.77% |
| Sep 30, 2012 | 28.21M | -4.94M | -14.89% |
| Sep 30, 2011 | 33.14M | 4.36M | 15.16% |
| Sep 30, 2010 | 28.78M | -3.00M | -9.45% |
| Sep 30, 2009 | 31.78M | -9.91M | -23.77% |
| Sep 30, 2008 | 41.70M | 1.94M | 4.89% |
| Sep 30, 2007 | 39.75M | -3.30M | -7.65% |
| Sep 30, 2006 | 43.05M | 653.00K | 1.54% |
| Sep 30, 2005 | 42.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| FONAR | 106.03M |
| Biodesix | 80.17M |
| Exagen | 63.60M |
| XWELL | 29.52M |
| Precipio | 22.80M |
| bioAffinity Technologies | 6.78M |
| iSpecimen | 3.35M |
| Mainz Biomed | 659.94K |
NOTV News
- 10 days ago - Inotiv Provides Notice Regarding Cybersecurity Incident - GlobeNewsWire
- 14 days ago - Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update - GlobeNewsWire
- 19 days ago - Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026 - GlobeNewsWire
- 5 weeks ago - Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery - GlobeNewsWire
- 2 months ago - Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities - GlobeNewsWire
- 2 months ago - Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update - GlobeNewsWire